EntryPoint Capital’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-10,337
Closed -$173K 861
2025
Q2
$173K Sell
10,337
-398
-4% -$7.02K 0.09% 512
2025
Q1
$189K Buy
+10,735
New +$215K 0.09% 549
2024
Q4
Sell
-15,700
Closed -$583K 949
2024
Q3
$583K Buy
+15,700
New +$586K 0.33% 24
2024
Q1
Sell
-1,244
Closed -$38.8K 1739
2023
Q4
$38.8K Buy
+1,244
New +$44.7K 0.04% 838

Other funds holding STAA

EntryPoint Capital's STAA Position: Q3 2025 in Review

EntryPoint Capital sold out of STAAR Surgical (STAA) in Q3 2025, closing a stake of 10,337 shares — an estimated $173K sold.

EntryPoint Capital first reported a position in STAA in Q4 2023 and held it in 4 quarters. The position peaked at $583K in Q3 2024. 196 funds tracked by Wall St. Rank hold STAA as of Q3 2025.

  • EntryPoint Capital reported no remaining STAAR Surgical position as of Q3 2025 after selling out during the quarter.
  • EntryPoint Capital sold 10,337 STAAR Surgical shares in Q3 2025, an estimated $173K.
  • EntryPoint Capital first reported a position in STAAR Surgical in Q4 2023 and held it in 4 quarters.
  • EntryPoint Capital's STAAR Surgical position peaked at $583K in Q3 2024.
  • 196 funds tracked by Wall St. Rank held STAAR Surgical as of Q3 2025.

Based on EntryPoint Capital's 13F filing for Q3 2025, filed 13 Nov 2025.